Case Study
For over two decades, Innovaderm has been the leading dermatology CRO and one of the largest dermatology Clinical Research Units (CRU) in North America. As we continue to grow and support immune-mediated diseases—including those in rheumatology, a therapeutic area inextricably linked to dermatology—we have rebranded the CRO side of our business to Indero. Innovaderm will continue to operate as a CRU for dermatology studies.
Dermatology is a diverse field of research with over 3,000 skin pathologies, greatly impacting patients’ quality of life. Many skin conditions require new treatment options—and Indero has been dedicated to this need for over 25 years. With deep medical expertise and extensive operational experience, we can help you design a study that meets scientific objectives with the well-being of patients in mind.
As your dermatology CRO, Indero provides expertise across a range of dermatological indications. Our team has a deep understanding of the intricacies of skin-related conditions, applying depth and precision to each study we support, including:
Indero conducts safety and efficacy studies in dermatology, both involving systemic and topically administered investigational products.
Indero offers a full-service in-house model for dermatology clinical trials. From design to execution, we provide customized solutions to meet your study’s unique needs.
Indero is a global clinical leader in dermatology with over a quarter century’s experience serving a broad range of indications, patient populations, administration routes, and drug classes. From protocol design to data delivery, we offer a full-service approach that equips biotech and pharmaceutical sponsors with the scientific rigor and targeted expertise to help bring novel therapies to people with skin diseases. Our operations span across the world, with capabilities in North America, Europe, Latin America, and Asia Pacific. Our dermatology connections include over 3,100+ investigators, making us a trusted partner for efficient, effective dermatology trials at a global scale.
“Indero’s flexibility and effective change management have been exceptional. They successfully integrated new study components, ensuring timelines were met and the project progressed seamlessly.”
Sr. Director, Clinical Operations
Innovaderm is a dermatology-focused Clinical Research Unit (CRU) well suited for single or multicenter dermatology studies. With a database of +90,000 patients, Innovaderm CRU has a dedicated team of study coordinators, lab technicians, research nurses, data entry specialists, regulatory specialists and recruitment professionals.
Indero has cultivated relationships with 3,100+ dermatology investigators around the world actively contributing to the advancement of novel therapies for people with skin conditions. Developed over years of working together we have strong relationships with these sites, allowing us to select the right sites for your trial. Our sites are ready to meet your enrollment requirements ensuring your timelines and quality metrics are met.
A late phase clinical trial for 148 subjects across 41 sites in North America and Europe required smart site and patient recruitment strategies to fulfill enrollment requirements.
Head of Clinical Operations
“Working with Indero for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration.”
Executive Chairman and Founder
Chief Medical and Scientific Officer
Dermatologist, Medical Monitor
Dermatologist, Medical Monitor Associate
| A Dermatology CRO specializes and understands the caveats and challenges of dermatology diseases and target populations. They combine medical, scientific and clinical dermatology expertise to ensure successful trial management and execution. |
When selecting a dermatology CRO, consider these key factors:
Wherever
You’re Going,
We’re all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
3530 Saint-Laurent Boulevard
Suite 300
Montreal, QC, H2X 2V1, Canada
© 2025 Indero. All Rights Reserved. Privacy Policy. Designed and developed by Altitude Marketing.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.
Leveraging an average of over 15 years of industry experience, our seasoned clinical operations team offers both adaptive monitoring services (on-site and remote) and centralized monitoring services. All of our team members undergo extensive dermatology training. We ensure compliance with dermatology study protocols, sound clinical practices and applicable regulations. Our team is skilled in identifying data inconsistencies, performing trend analysis, and detecting patterns or outliers. Additionally, we offer tailored training programs for sites in dermatology to ensure they are well-equipped with the latest knowledge and best practices.
We provide clinical oversight to protect subject safety and maintain data integrity. Our responsive medical monitors work directly with sites to address issues quickly, ensuring adherence and reliable data that keep your dermatology trials on track.
Our pharmacovigilance services span various therapeutic areas and track, assess, and report safety data to manage your trial risks effectively. Through continuous monitoring and regulatory reporting, we ensure subject safety, providing you with the confidence and clarity you need.
Our extensive biometric services cater to all your biostatistics and data management requirements, meticulously aligned with your dermatology study goals and other medical fields. We offer a range of services, including adaptive design, strategic statistical consulting, sample size and power calculations, database design, medical coding, and thorough data validation, review, and cleaning.
With deep dermatology expertise and vast operational experience, we can help you design an innovative and efficient patient-centric dermatology study that meets your scientific objectives while optimizing your financial investment. We engage key opinion leaders to shape trial designs leading to improved study site engagement.
We can help you navigate the global regulatory landscape and provide clinical development consulting, covering end-to-end needs, including drug and device submissions, medical and scientific writing, clinical pre-feasibility, scientific support, and even meeting with regulatory agencies.
Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.
We provide expert scientific and regulatory writing services, delivering high-quality clinical study protocols designed and drafted by our team of clinical scientists, dermatologists, and operations specialists, with contributions from clinical study coordinators at Innovaderm, our clinical research unit (CRU), all tailored to your requirements and specifications.
Our quality assurance service ensures the highest standards of compliance and data integrity. We implement rigorous quality control processes to identify and mitigate risks early.
We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Innovaderm will continue to operate as a CRU for dermatology studies.
Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
